Azintuxizumab

Item number	Size	Datasheet	Manual	SDS	Delivery time	Price
TGM-T82927-1mg	1 mg				5 - 10 business days*	233.00€
TGM-T82927-5mg	5 mg				5 - 10 business days*	707.00€
TGM-T82927-10mg	10 mg	-	-	-	5 - 10 business days*	1,137.00€

If you have any questions, please use our Contact Form.
You can also order by e-mail: info@biomol.com
Larger quantity required? Request bulk

Description: Azintuxizumab, an IgG4 bispecific antibody, is designed to specifically recognize... more

Close menu

Product information "Azintuxizumab"

Description: Azintuxizumab, an IgG4 bispecific antibody, is designed to specifically recognize and bind to the B-cell maturation antigen (BCMA), a molecular marker associated with plasma cell malignancies. Azintuxizumab shows significant promise in preclinical and translational research investigating therapeutic interventions for relapsed or refractory multiple myeloma (RRMM), thereby providing a dual-targeted mechanism of action for antibody-based immunotherapy. Target: TNF. References: International Nonproprietary Names for Pharmaceutical Substances (INN). WHO Drug Information, Vol. 31, No. 3, 2017.